Atom enrolls first patient in global phase 2 trial of ABP-745 for acute gout flares
ABP-745 is a novel oral therapy with potential applications in cardiovascular and other inflammatory diseases
ABP-745 is a novel oral therapy with potential applications in cardiovascular and other inflammatory diseases
Dr. Brown brings extensive international experience in oncology and radiopharmaceutical development,
Launches National IVD validation portal and protocols; highlights India’s strengthening health research ecosystem
Philips and Masimo will also collaborate on the development and co-promotion of next-generation monitoring solutions
The FDA is beginning rulemaking to close the “adequate provision” loophole
Cagrilintide represents a novel approach to obesity management
Tagrisso plus chemotherapy achieves nearly four-year median overall survival in EGFR-mutated advanced lung cancer, setting new global standard in phase III trial
Alembic receives EIR from USFDA for facility at Panelav
Subscribe To Our Newsletter & Stay Updated